Globus Medical, Inc. (GMED) |
56.57 -3.04 (-5.1%) 10-10 16:00 |
Open: | 59.75 |
High: | 59.895 |
Low: | 56.5 |
Volume: | 1,038,899 |
Market Cap: | 7,640(M) |
PE Ratio: | 21.93 |
Exchange: | New York Stock Exchange |
Industry: | Medical - Devices |
Sector: | Healthcare |
Technical analysis | ||||
![]() |
||||
sell | buy |
Resistance 2: | 61.62 |
Resistance 1: | 58.77 |
Pivot price: | 57.78 |
Support 1: | 54.15 |
Support 2: | 45.05 |
52w High: | 94.93 |
52w Low: | 51.79 |
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
EPS | 2.580 |
Book Value | 31.810 |
PEG Ratio | 0.00 |
Gross Profit | 15.626 |
Profit Margin (%) | 13.58 |
Operating Margin (%) | 17.33 |
Return on Assets (ttm) | 5.8 |
Return on Equity (ttm) | 8.6 |
Fri, 10 Oct 2025
Myriad Genetics, Omnicell, Globus Medical, Repligen, and Teleflex Stocks Trade Down, What You Need To Know - TradingView
Tue, 07 Oct 2025
Can Globus Medical’s (GMED) Global Expansion Unlock Sustainable Returns for Investors? - Sahm
Mon, 06 Oct 2025
Winners And Losers Of Q2: Globus Medical (NYSE:GMED) Vs The Rest Of The Medical Devices & Supplies - Specialty Stocks - The Globe and Mail
Sat, 04 Oct 2025
Globus Medical (GMED): Evaluating Valuation After New Products, Growth, and ROIC Slowdown - Sahm
Mon, 29 Sep 2025
Here's Why Globus Medical (GMED) is a Strong Value Stock - Yahoo Finance
Fri, 12 Sep 2025
Should You Think About Buying Globus Medical, Inc. (NYSE:GMED) Now? - simplywall.st
![]() StockChart iOS |
![]() StoxlineLite iOS |
![]() StoxlineLite iOS |
![]() OptionCalc iOS |
![]() StockChart Android |
![]() StoxlineLite Android |
![]() StoxlinePro Android |
![]() OptionCalc Android |